Operative procedures for unresectable pancreatic cancer: Does operative bypass decrease requirements for postoperative procedures and in-hospital days?

Published

Journal Article

Background: The optimal surgical management of patients found to have unresectable pancreatic cancer at open exploration remains unknown. Methods: Records of patients who underwent non-therapeutic laparotomy for pancreatic cancer during 2000-2009 and were followed until death at Memorial Sloan-Kettering Cancer Center, New York, were reviewed. Results: Over the 10-year study period, 157 patients underwent non-therapeutic laparotomy. Laparotomy alone was performed in 21% of patients; duodenal bypass, biliary bypass and double bypass were performed in 11%, 30% and 38% of patients, respectively. Complications occurred in 44 (28%) patients. Three (2%) patients died perioperatively. Postoperative interventions were required in 72 (46%) patients following exploration. The median number of inpatient days prior to death was 16 (interquartile range: 8-32 days). Proportions of patients requiring interventions were similar regardless of the procedure performed at the initial operation, as were the total number of inpatient days prior to death. Patients undergoing gastrojejunostomy required fewer postoperative duodenal stents and those undergoing operative biliary drainage required fewer postoperative biliary stents. Conclusions: In this study, duodenal, biliary and double bypasses in unresectable patients were not associated with fewer invasive procedures following non-therapeutic laparotomy and did not appear to reduce the total number of inpatient hospital days prior to death. Continued effort to identify unresectability prior to operation is justified. © 2012 International Hepato-Pancreato-Biliary Association.

Full Text

Duke Authors

Cited Authors

  • Lyons, JM; Karkar, A; Correa-Gallego, CC; D'Angelica, MI; Dematteo, RP; Fong, Y; Kingham, TP; Jarnagin, WR; Brennan, MF; Allen, PJ

Published Date

  • January 1, 2012

Published In

Volume / Issue

  • 14 / 7

Start / End Page

  • 469 - 475

Electronic International Standard Serial Number (EISSN)

  • 1477-2574

International Standard Serial Number (ISSN)

  • 1365-182X

Digital Object Identifier (DOI)

  • 10.1111/j.1477-2574.2012.00477.x

Citation Source

  • Scopus